Dr. Greten is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Nci Building 10 Rm 12n226
10 Center Drive
Bethesda, MD 20892Phone+1 240-760-6114
Education & Training
- University of Kiel Faculty of MedicineClass of 1992
Certifications & Licensure
- MD State Medical License 2011 - 2026
Clinical Trials
- Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma Start of enrollment: 2007 Feb 01
- Sorafenib and TRC105 in Hepatocellular Cancer Start of enrollment: 2011 Feb 11
- Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer Start of enrollment: 2011 Mar 02
- Join now to see all
Publications & Presentations
PubMed
- 193 citationsGut microbiome in HCC – Mechanisms, diagnosis and therapyRobert F. Schwabe, Tim F. Greten
Journal of Hepatology. 2020-02-01 - 4424 citationsMismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T. Le, Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne Bartlett
Science. 2017-07-28 - 78 citationsAdjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy.Tim F. Greten, Bernd Heinrich
Hepatology. 2019-10-01
Press Mentions
- Drugs for Advanced Breast Cancer Could Help Patients with Rare Cancer That Affects Bile DuctsOctober 23rd, 2024
- Treatments Used for HER2-Positive Breast Cancers Could Help Patients with Rare Gastrointestinal CancerOctober 23rd, 2024
- Roundtable Discussion: Has Interventional Oncology Established Itself as the Fourth Pillar of Oncology?October 24th, 2022
- Join now to see all
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: